New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

LOQTORZI (toripalimab-tpzi) injection

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call at 9891296838 or Email query@southdelhipharma.com to discuss.

LOQTORZI is a programmed death receptor-1 (PD-1)- blocking antibody – indicated:

  • in combination with cisplatin and gemcitabine, for first-line treatment of adults with metastatic or with recurrent locally advanced nasopharyngeal carcinoma (NPC).
  • as a single agent for the treatment of adults with recurrent unresectable or metastatic NPC with disease progression on or after a platinum-containing chemotherapy

Drug Name: LOQTORZI
Active Ingredient: TORIPALIMAB-TPZI
Company: COHERUS BIOSCIENCES INC
Approval Date: 27-Oct-2023
FDA-approved use on approval date: In combination with cisplatin and gemcitabine, for first-line treatment of adults with metastatic or with recurrent, locally advanced nasopharyngeal carcinoma (NPC); and Loqtorzi, as a single agent, for the treatment of adults with recurrent unresectable or metastatic NPC with disease progression on or after a platinumcontaining chemotherapy
Dosage Forms And Strengths: Injection: 240 mg/6 mL (40 mg/mL) solution in a single-dose vial

Do you need this medicine in India?

To help you get this medicine – LOQTORZI (toripalimab-tpzi), a prescription from the Registered Medical Practitioner (RMP) is required. Contact Mr. Tarun at 9891296838 via Call or WhatsApp for availability in India.

Category
LOQTORZI (toripalimab) cost Price Delhi India
Category

Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Query Form

Description

Toripalimab is indicated in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma. It is also indicated as a single agent for adults with recurrent unresectable or metastatic nasopharyngeal carcinoma with disease progression on or after a platinum-containing chemotherapy.

LOQTORZI (toripalimab-tpzi) injection, for intravenous use Initial U.S. Approval: 2023

See full prescribing information : Click Here

Need Help Getting Medicine? Here’s How We Can Assist You.

Brand Name “LOQTORZI” or Generic Name “toripalimab-tpzi” can be imported for personal use under “Named Patient Program” treatment in Delhi, Kolkata, Surat, Jaipur, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla, Ahmedabad, Jodhpur, Mumbai, Jaipur, Aurangabad, Pune, Bangalore, Hyderabad, Chennai, Visakhapatnam, Coimbatore, Andhra Pradesh, Karnataka, Kerala, Lakshadweep, Puducherry, Tamil Nadu, Telangana, India. Contact us at support@southdelhipharma.net, southdelhipharma@gmail.com or  you can call at 9891296838 or WhatsApp at 9891296838

Related Products

Related products